Cargando…

Evaluation of the Effect of Topiroxostat on Renal Function in Patients with Hyperuricemia: STOP-C Study, a Retrospective Observational Cohort Study

BACKGROUND: Serum uric acid-lowering therapy is associated with maintaining renal function. OBJECTIVE: We aimed to retrospectively evaluate renal function and serum uric acid in patients with hyperuricemia who received topiroxostat for over a year. METHODS: Medical records of patients from 1 January...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tamiya, Eiji, Yamashita, Haruyo, Takabe, Tomosato, Matsumoto, Takahiro, Kajihara, Jun, Yamamoto, Shouichi, Kanoh, Tatsuji, Koide, Hikaru, Minamino, Tohru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114256/ https://www.ncbi.nlm.nih.gov/pubmed/35094305 http://dx.doi.org/10.1007/s40801-022-00291-w

Ejemplares similares

SAT-079 Renal Protective Effects Of Topiroxostat And Febuxostat In Hypertensives With Hyperuricemia.
por: Satoh, Fumitoshi, et al.
Publicado: (2019)

Comparative effects of topiroxostat and febuxostat on arterial properties in hypertensive patients with hyperuricemia
por: Kario, Kazuomi, et al.
Publicado: (2021)

Changeover Trial of Febuxostat and Topiroxostat for Hyperuricemia with Cardiovascular Disease: Sub-Analysis for Chronic Kidney Disease (TROFEO CKD Trial)
por: Sezai, Akira, et al.
Publicado: (2019)

Renoprotective Effect of Xanthine Oxidase Inhibitor, Topiroxostat
por: Katsuyama, Hisayuki, et al.
Publicado: (2019)

The effect for hyperuricemia inpatient of uric acid overproduction type or in combination with topiroxostat on the pharmacokinetics, pharmacodynamics and safety of dotinurad, a selective urate reabsorption inhibitor
por: Okui, Daisuke, et al.
Publicado: (2019)

Topiroxostat versus allopurinol in patients with chronic heart failure complicated by hyperuricemia: A prospective, randomized, open-label, blinded-end-point clinical trial
por: Sakuma, Masashi, et al.
Publicado: (2022)

Renoprotective effect of topiroxostat via antioxidant activity in puromycin aminonucleoside nephrosis rats
por: Kawamorita, Yosuke, et al.
Publicado: (2017)

Influence of xanthine oxidoreductase inhibitor, topiroxostat, on body weight of diabetic obese mice
por: Nakamura, Takashi, et al.
Publicado: (2021)

Randomized control trial for the assessment of the anti-albuminuric effects of topiroxostat in hyperuricemic patients with diabetic nephropathy (the ETUDE study)
por: Kato, Sawako, et al.
Publicado: (2016)

Multicenter, Open-Label Study of Long-Term Topiroxostat (FYX-051) Administration in Japanese Hyperuricemic Patients with or Without Gout
por: Hosoya, Tatsuo, et al.
Publicado: (2018)

Effects of topiroxostat on the serum urate levels and urinary albumin excretion in hyperuricemic stage 3 chronic kidney disease patients with or without gout
por: Hosoya, Tatsuo, et al.
Publicado: (2014)

Clinical efficacy and safety of topiroxostat in Japanese hyperuricemic patients with or without gout: a randomized, double-blinded, controlled phase 2b study
por: Hosoya, Tatsuo, et al.
Publicado: (2016)

The Effects of Topiroxostat, a Selective Xanthine Oxidoreductase Inhibitor, on Arterial Stiffness in Hyperuricemic Patients with Liver Dysfunction: A Sub-Analysis of the BEYOND-UA Study
por: Fujishima, Yuya, et al.
Publicado: (2023)

Clinical Effects of Topiroxostat on Renal and Endothelial Function in A Patient with Chronic Kidney Disease and Hyperuricemic Arteriolopathy: A Case Report
por: Tanaka, Atsushi, et al.
Publicado: (2017)

Effect of hyperuricemia and treatment for hyperuricemia in Japanese hemodialysis patients: A cohort study
por: Sugano, Naoki, et al.
Publicado: (2019)

Association between dietary approaches to stop hypertension (DASH) diet and hyperuricemia among Chinese adults: findings from a nationwide representative study
por: Zhu, Qianrang, et al.
Publicado: (2023)

Long-Term Safety and Effectiveness of the Xanthine Oxidoreductase Inhibitor, Topiroxostat in Japanese Hyperuricemic Patients with or Without Gout: A 54-week Open-label, Multicenter, Post-marketing Observational Study
por: Ishikawa, Tomohiko, et al.
Publicado: (2020)

Study of the reverse transition in pipe flow
por: Yokoo, Hikaru, et al.
Publicado: (2023)

Study of epidemiological aspects of hyperuricemia in Poland
por: Kostka-Jeziorny, Katarzyna, et al.
Publicado: (2019)

Prevalence and factors related to hypouricemia and hyperuricemia in schoolchildren: results of a large-scale cross-sectional population-based study conducted in Japan
por: Aoki, Yuhei, et al.
Publicado: (2022)

Recent Advances in the Bacterial Flagellar Motor Study
por: Minamino, Tohru, et al.
Publicado: (2021)

Febuxostat for Hyperuricemia in Patients with Advanced Chronic Kidney Disease
por: Akimoto, Tetsu, et al.
Publicado: (2014)

Hyperuricemia and dementia – a case-control study
por: Engel, Bettina, et al.
Publicado: (2018)

Impact of hyperuricemia on mortality related to aortic diseases: a 3.8-year nationwide community-based cohort study
por: Otaki, Yoichiro, et al.
Publicado: (2020)

Variation of Urate Transport in the Nephrons in Subtypes of Hyperuricemia
por: Nakamura, Toru, et al.
Publicado: (2013)

Influence of hyperuricemia treatment on postoperative acute kidney injury among hyperuricemia patients: a single-center retrospective database analysis
por: Watanabe, Shinichiro, et al.
Publicado: (2019)

Different clinical impact of hyperuricemia according to etiologies of chronic kidney disease: Gonryo Study
por: Watanabe, Kimio, et al.
Publicado: (2021)

Identifying Cerebral Large Vessel Occlusion in Acute Ischemic Stroke by MRI Positioning Scanning
por: YAMASHITA, Shota, et al.
Publicado: (2021)

Extreme hyperuricemia is a risk factor for infection-related deaths in incident dialysis patients: a multicenter prospective cohort study
por: Yoshida, Hiroyuki, et al.
Publicado: (2020)

Thermal imaging of spin Peltier effect
por: Daimon, Shunsuke, et al.
Publicado: (2016)

Epidemiology of hyperuricemia in the elderly.
por: Lai, S. W., et al.
Publicado: (2001)

Hyperuricemia and Cardiovascular Risk
por: Shahin, Lauren, et al.
Publicado: (2021)

Hypertriglyceridemia and hyperuricemia: a retrospective study of urban residents
por: Hou, Yan-long, et al.
Publicado: (2019)

RBP4 Is Associated With Insulin Resistance in Hyperuricemia-Induced Rats and Patients With Hyperuricemia
por: Liu, Chan, et al.
Publicado: (2021)

Feasibility of Simple Evaluation of Coronary Artery Calcium Using a Number of Chest Computed Tomography Slices: A Multicenter Study
por: Yamamoto, Hideya, et al.
Publicado: (2023)

Quantitative Estimation of Urate Transport in Nephrons in Relation to Urinary Excretion Employing Benzbromarone-Loading Urate Clearance Tests in Cases of Hyperuricemia
por: Nakamura, Toru, et al.
Publicado: (2011)

The altered gut microbiota of high-purine-induced hyperuricemia rats and its correlation with hyperuricemia
por: Liu, Xiu, et al.
Publicado: (2020)

Stop! Stop!
Publicado: (1913)

Adolescent Hyperuricemia with Lipid Storage Myopathy: A Clinical Study
por: Han, Jingzhe, et al.
Publicado: (2019)

Favipiravir and hyperuricemia in patients with COVID-19—suggestions for future studies
por: Kow, Chia Siang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6fkk95po9opj24vntiruihtah3